Mereo BioPharma Group PLC
MREO1.870USD
+0.030+1.63%
Close 11/28, 13:00（ET）Quotes delayed by 15 min
1.49BMarket Cap
LossP/E TTM
Mereo BioPharma Group PLC Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
--
-100.00%
EPS(YoY)
-0.30
-34.29%
Analyst Rating
STRONG BUY
2025-11-30
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Mereo BioPharma Group PLC?
According to Mereo BioPharma Group PLC's FY2024 earnings report, its total revenue reached --, with a year-on-year change of -100.00%.
What is the Earnings Per Share (EPS) of Mereo BioPharma Group PLC?
According to Mereo BioPharma Group PLC's FY2024 earnings report, its Earnings Per Share (EPS) was -0.300, with a year-on-year change of -34.29%.
What is the net income of Mereo BioPharma Group PLC?
According to Mereo BioPharma Group PLC's FY2024 earnings report, its net income was --, with a year-on-year change of --.
What is the net margin of Mereo BioPharma Group PLC?
According to Mereo BioPharma Group PLC's FY2024 earnings report, its net profit margin was --, with a year-on-year change of --.
What is the gross margin of Mereo BioPharma Group PLC?
According to Mereo BioPharma Group PLC's FY2024 earnings report, its gross margin was --, with a year-on-year change of --.
What is the debt-to-asset ratio of Mereo BioPharma Group PLC?
According to Mereo BioPharma Group PLC's FY2024 earnings report, its debt-to-asset ratio was 7.25%, with a year-on-year change of 9.66%.
What is the Return on Equity (ROE) of Mereo BioPharma Group PLC?
According to Mereo BioPharma Group PLC's FY2024 earnings report, its Return on Equity (ROE) was --, with a year-on-year change of --.
What is the Return on Assets (ROA) of Mereo BioPharma Group PLC?
According to Mereo BioPharma Group PLC's FY2024 earnings report, its Return on Assets (ROA) was --, with a year-on-year change of --.
What is the operating profit of Mereo BioPharma Group PLC?
According to Mereo BioPharma Group PLC's FY2024 earnings report, its operating profit was -47.36M, with a year-on-year change of -66.68%.
What are the current assets of Mereo BioPharma Group PLC?
According to Mereo BioPharma Group PLC's FY2024 earnings report, its current assets were 74.76M, with a year-on-year change of 17.26%.
What are the total assets of Mereo BioPharma Group PLC?
According to Mereo BioPharma Group PLC's FY2024 earnings report, its total assets of Mereo BioPharma Group PLC were 76.39M, with a year-on-year change of 14.87%.
What are the total liabilities of Mereo BioPharma Group PLC?
According to Mereo BioPharma Group PLC's FY2024 earnings report, its total liabilities of Mereo BioPharma Group PLC were 15.42M, with a year-on-year change of -3.39%.
What is the total equity of Mereo BioPharma Group PLC?
According to Mereo BioPharma Group PLC's FY2024 earnings report, its total equity of Mereo BioPharma Group PLC was 60.97M, with a year-on-year change of 20.64%.
What is the net operating income of Mereo BioPharma Group PLC?
According to Mereo BioPharma Group PLC's FY2024 earnings report, its net operating income of Mereo BioPharma Group PLC was -43.25M, with a year-on-year change of -46.79%.
What is the net investment of Mereo BioPharma Group PLC?
According to Mereo BioPharma Group PLC's FY2024 earnings report, its net investment of Mereo BioPharma Group PLC was -699.00K, with a year-on-year change of -66.83%.
What is the net financing of Mereo BioPharma Group PLC?
According to Mereo BioPharma Group PLC's FY2024 earnings report, its net financing of Mereo BioPharma Group PLC was 46.15M, with a year-on-year change of 478.79%.
